Alignment Healthcare, Inc.
General ticker "ALHC" information:
- Sector: Health Care
- Industry: Medical - Healthcare Plans
- Capitalization: $3.0B (TTM average)
Alignment Healthcare, Inc. follows the US Stock Market performance with the rate: 40.7%.
Estimated limits based on current volatility of 1.8%: low 20.69$, high 21.36$
Factors to consider:
- Total employees count: 1679 (+9.3%) as of 2024
- Company does not operate outside North America (retrieved using AI)
- Top business risk factors: History of net losses and potential unprofitability, Limited operating history, Strategic risks and growth management, Senior management dependency, Regulatory and compliance
- Price in estimated range
Stock Forecast*
* forecast is subjective and experimental, should not be used for any investment decisions
Long term estimates were made for the period from 2025-12-31 to 2027-12-31
- 2025-12-31 to 2026-12-31 estimated range: [12.73$, 21.87$]
- 2026-12-31 to 2027-12-31 estimated range: [13.62$, 23.31$]
Financial Metrics affecting the ALHC estimates:
- Positive: with PPE of -1969.6 at the end of fiscal year the price was neutral
- Positive: -4.72 < Operating profit margin, % of 0.37
- Positive: Industry inventory ratio change (median), % of 0.09 <= 0.31
- Negative: Shareholder equity ratio, % of 16.82 <= 19.49
- Positive: Inventory ratio change, % of 0 <= 0
- Positive: Investing cash flow per share per price, % of -0.38 > -0.65
- Positive: -3.36 < Return on assets ratio (scaled to [-100,100]) of -0.09
- Positive: 0.07 < Operating cash flow per share per price, % of 3.59
- Positive: -8.75 < Industry operating profit margin (median), % of 0.76
Short-term ALHC quotes
Long-term ALHC plot with estimates
Financial data
| YTD | 2023-12-31 | 2024-12-31 | 2025-12-31 |
|---|---|---|---|
| Operating Revenue | $1,823.63MM | $2,703.56MM | $3,948.72MM |
| Operating Expenses | $1,951.45MM | $2,805.12MM | $3,933.97MM |
| Operating Income | $-127.82MM | $-101.56MM | $14.75MM |
| Non-Operating Income | $-20.38MM | $-26.50MM | $-15.71MM |
| Interest Expense | $21.23MM | $23.55MM | $15.80MM |
| Income(Loss) | $-148.19MM | $-128.05MM | $-0.96MM |
| Taxes | $-0.02MM | $0.02MM | $0.02MM |
| Profit(Loss)* | $-148.02MM | $-128.03MM | $-0.72MM |
| Stockholders Equity | $156.95MM | $99.85MM | $179.28MM |
| Assets | $591.88MM | $782.06MM | $1,065.79MM |
| Operating Cash Flow | $-59.19MM | $34.77MM | $139.93MM |
| Capital expenditure | $35.99MM | $41.42MM | $26.78MM |
| Investing Cash Flow | $-147.26MM | $39.19MM | $-14.97MM |
| Financing Cash Flow | $0.10MM | $156.03MM | $18.04MM |
| Earnings Per Share** | $-0.79 | $-0.67 | $-0.00 |
* Profit(Loss) attributable to entity.
** EPS are Split Adjusted, recent splits may be reflected with a delay.